Alterity Therapeutics Limited

ATHE | NASDAQ

$3.83

+$0.05 (+1.32%)

Sep 22, 2026, 2:17 PM ET · Market open

Fiscal Year Period Ending	FY 2026 Jun 29, 2026	FY 2025 Jun 29, 2025	FY 2024 Jun 29, 2024	FY 2023 Jun 29, 2023	FY 2022 Jun 29, 2022	FY 2021 Jun 29, 2021
Net Income	-22.89M	-12.15M	-19.12M	-13.81M	-12.85M	-15.31M
Depreciation & Amortization	113.01K	139.72K	147.53K	102.26K	54.21K	75.37K
Stock-Based Compensation	n/a	979.92K	881.95K	966.57K	1.51M	1.88M
Other Working Capital	600.06K	-717.75K	23.05K	-889.52K	-393.29K	-624.03K
Other Non-Cash Items	4.36M	190.62K	-261.15K	-6.35M	455.57K	-2.1M
Deferred Income Tax	n/a	n/a	n/a	2.99M	-1.06M	2.33M
Change in Working Capital	-3.62M	-613.68K	5.75M	-3.94M	-447.68K	-4.22M
Operating Cash Flow	-22.03M	-11.45M	-12.61M	-20.04M	-12.34M	-17.33M
Capital Expenditures	22.03M	3	-5.72K	-7.31K	-89.15K	-10.47K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-7.5M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	7.34M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-29.15K	n/a	n/a
Investing Cash Flow	7.34M	-7.5M	-5.72K	-36.46K	-89.15K	-10.47K
Debt Repayment	n/a	-127.1K	-10.37K	-59.92K	-34.51K	-58.29K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-133.57K	-2.77M	-918.02K	-132.41K	-836.97K	-2.49M
Financial Cash Flow	18.71M	39.67M	9.22M	124.34K	16.3M	36.69M
Net Cash Flow	5.95M	20.52M	-3.13M	-19.03M	6.69M	18.92M
Free Cash Flow	n/a	-11.45M	-12.61M	-20.04M	-12.43M	-17.34M
Adj. Free Cash Flow	n/a	-12.43M	-13.49M	-21.01M	-13.93M	-19.23M
Maintenance CapEx	22.03M	6	-126	-7.31K	-45.31K	n/a
Growth CapEx	n/a	-3	-5.6K	n/a	-43.84K	-10.47K
Owner Earnings	n/a	-11.45M	-12.61M	-20.04M	-12.38M	-17.33M